MedPath

Microvascular flow and microvascular blood volume measurements in human skeletal muscle using contrast enhanced ultrasound (CEUS).

Completed
Conditions
microvascular insulin resistance
obesity
10018424
10057166
Registration Number
NL-OMON38401
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
8
Inclusion Criteria

1. Age 18-55 years
2. BMI < 25 kg/m2 *;* = most likely to have intact capillary recruitment in skeletal muscle (a parameter studied in this research protocol).

Exclusion Criteria

1. Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, heart failure, cardiac shunts, heart valve replacement, pulmonary hypertension).
2. Pulmonary disease.
3. Diabetes mellitus (FPG > 7.8 mmol/L).
4. Smoking.
5. Hypertension (>140/90 mmHg).
6. Alcohol use > 4 U/day.
7. Use of medication (antihypertensive medication, statins, corticosteroids, NSAIDs, ciclosporin A, rifampicin).
8. Pregnancy or lactation.
9. Insufficient knowledge of the Dutch language.
10. Known allergic reaction to ultrasound contrast-agent.
11. Known cardiac dysrhythmias (e.g. atrial fibrillation, long QT-syndrome) or a family history of cardiac dysrhythmias or sudden cardiac death.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Intra-observer variability and day-to-day variation of forearm skeletal<br /><br>muscle CEUS measurements.<br /><br>2. The percentage change in microvascular blood volume (MBV), flow and flow<br /><br>velocity (MFV), measured by means of CEUS signal, in forearm skeletal muscle<br /><br>from baseline to post-exercise status.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Inter-observer variability in offline analysis of CEUS measurements.<br /><br>2. Skeletal muscle microvascular flow distribution.<br /><br>3. Change in skeletal muscle microvascular flow distribution from baseline to<br /><br>post-exercise status.</p><br>
© Copyright 2025. All Rights Reserved by MedPath